RecruitingNot applicableNCT06857708

The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®

Studying Necrotizing soft tissue infection

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Benjamin T. Miller
Intervention: Cytal® Wound Matrix(device)
Enrollment: 50 enrolled
Eligibility: 18 years · All sexes
Timeline: 2025 – 2026

Study locations (1)

Cleveland Clinic, Cleveland, Ohio, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06857708 on ClinicalTrials.gov

Other trials for Necrotizing soft tissue infection

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNCT07107555
Necrotizing Soft Tissue Infections
European Society for Trauma and Emergency Surgery
RECRUITINGNANCT07120386
Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections
HealthPartners Institute
RECRUITINGNANCT03482245
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
Washington University School of Medicine
RECRUITINGNCT06002607
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
University of California, Irvine
RECRUITINGNCT07359651
FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
University of Cagliari

See all trials for Necrotizing soft tissue infection →

← Back to all trials